Mark Corrigan
About Mark Corrigan
Mark Corrigan's Professional Titles
Mark Corrigan currently serves as Chairman of the Board of Exacis Therapeutics. He is also a Board Member who has held various leadership roles in the pharmaceutical industry. Previously, he co-founded Tremeau Pharmaceuticals, Inc. in 2016. Mark has also served as Director, President, and Chief Executive Officer of Zalicus, Inc. from 2010 to 2014.
Mark Corrigan's Education and Medical Expertise
Mark Corrigan holds both a Bachelor of Science and an MD from the University of Virginia School of Medicine. He maintains an academic role as an Adjunct Professor in the Psychiatry Department at the University of North Carolina at Chapel Hill School of Medicine. His medical and academic background has significantly contributed to his expertise in pharmaceutical research and development.
Mark Corrigan's Pharmaceutical Industry Experience
Mark Corrigan has extensive experience in the pharmaceutical industry. He served as Executive Vice President of Research and Development at Sepracor Inc. before taking on a leadership role at Zalicus, Inc. He also spent 10 years with Pharmacia & Upjohn as Group Vice President of Global Clinical Research and Experimental Medicine, where he contributed significantly to global clinical research initiatives.
Mark Corrigan's Board Memberships
Mark Corrigan has actively contributed to various boards in the pharmaceutical sector. He served on the board of directors of Cubist Pharmaceuticals, where he chaired the Scientific Committee. He also served on the board of directors of Avanir Pharmaceuticals, Inc., acting as chair of the Scientific Advisory Committee (SAC). His board memberships reflect his commitment to advancing pharmaceutical research and development.